drugset / Trial / NCT00356421

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

NCT00356421

Phase 4 Terminated 58 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare efficacy and safety of Exubera® vs Humalog in patients with type 1 diabetes mellitus

Timeline

Start
2006-11
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled
Comparator Insulin Lispro Protein / enzyme biologic Subcutaneous
Background insulin glargine Protein / enzyme biologic